Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome
A. A. Cooke; R. M. Connaughton; C. L. Lyons; A. M. McMorrow; H. M. Roche
Year of publication
Eur J Pharmacol
The metabolic syndrome is a group of obesity associated metabolic conditions that result in increased risk of cardiovascular disease and type 2 diabetes. Global increases in obesity rates have led to an increase in metabolic syndrome resulting in a demand for increased understanding of the mechanisms involved. This review examines the relationship between adipose tissue biology, lipid metabolism and chronic low grade inflammation relating to obesity and insulin resistance.